{"id":687934,"date":"2022-09-22T07:49:22","date_gmt":"2022-09-22T11:49:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/"},"modified":"2022-09-22T07:49:22","modified_gmt":"2022-09-22T11:49:22","slug":"generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/","title":{"rendered":"Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CAMBRIDGE, Mass., Sept.  22, 2022  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pc-slbs5XsYsOTVIW9iCkWjpy_-c9qb_deYc0_Doe7kSOb2Hwl2ImKz2uiEZ9RUf6o0Y2gqCFdHsSru8eIkeJEoKeDh3Otl5ZbtIXFyEyEE=\" rel=\"nofollow noopener\" target=\"_blank\">Generation Bio Co.<\/a> (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that the company will participate in a fireside chat at the 2022 Jefferies Cell &amp; Genetic Medicine Summit on Thursday, September 29th at 10:30 a.m. ET in New York.<\/p>\n<p>A live webcast of the presentation will be available on the investor section of the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BBZlx8xNzryY_djU0BT1Fo08TZxFJ--EfkHP2rQZLmjskI9HZFf7Gh31jPWeITI9nZzKCoQTF7dAVsqndCk_OhwDR-yfq54ZXKQh3NNG5l-VO5TrUUIKloBcw6aqSRpM\" rel=\"nofollow noopener\" target=\"_blank\">investors.generationbio.com<\/a>. A replay will be available there for 30 days following the event.<\/p>\n<p>\n        <strong>About Generation Bio<\/strong><br \/>\n        <br \/>Generation Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company\u2019s non-viral genetic medicine platform incorporates a novel DNA construct called closed-ended DNA, or ceDNA; a unique cell-targeted lipid nanoparticle delivery system, or ctLNP; and a highly scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis, or RES, to produce ceDNA. The platform is designed to enable multi-year durability from a single dose, to deliver large genetic payloads, including multiple genes, to specific cell types, and to allow titration and redosing to adjust or extend expression levels in each patient. RES has the potential to expand Generation Bio\u2019s manufacturing scale to hundreds of millions of doses to support its mission to extend the reach of genetic medicine to more people, living with more diseases, around the world.<\/p>\n<p>For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZyCersA47nqlzyGjGx5qcapuH3oGjw_BeEHcOfhmHVN9FKLNzEz6xfwmAHkwclcWAg6hnvKNC0qysTYoWmyMMAKbeEa07WO_UIFDrcHAHSU=\" rel=\"nofollow noopener\" target=\"_blank\">www.generationbio.com<\/a>.\u00a0<\/p>\n<p>\n        <strong>Investors\u00a0and Media Contact<\/strong><br \/>\n        <br \/>Maren Killackey<br \/>Generation Bio<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=izvqdgqOlELTMhMdSpvxSkpeTMRSCDzddEtTod2faCmIHbmwCSLjUIwLyCG29WnVHPgsatfBfyKoO9eOsoqs9Kjfk-VYMgtLtH0v1mjIHmrd5wRb-Z43oGW02s7Keqa3\" rel=\"nofollow noopener\" target=\"_blank\">mkillackey@generationbio.com<\/a><br \/>857-371-4638<\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTM4NiM1MTY1OTM4IzIxOTY5Mjg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MjcxMDZmMTctYTQxMy00MzE5LWJlMDQtOTYwMjczZmU1YzQyLTEyMDg0ODE=\/tiny\/Generation-Bio-Co-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) &#8212; Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that the company will participate in a fireside chat at the 2022 Jefferies Cell &amp; Genetic Medicine Summit on Thursday, September 29th at 10:30 a.m. ET in New York. A live webcast of the presentation will be available on the investor section of the company\u2019s website at investors.generationbio.com. A replay will be available there for 30 days following the event. About Generation Bio Generation Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company\u2019s non-viral genetic medicine platform incorporates a novel DNA &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-687934","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) &#8212; Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that the company will participate in a fireside chat at the 2022 Jefferies Cell &amp; Genetic Medicine Summit on Thursday, September 29th at 10:30 a.m. ET in New York. A live webcast of the presentation will be available on the investor section of the company\u2019s website at investors.generationbio.com. A replay will be available there for 30 days following the event. About Generation Bio Generation Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company\u2019s non-viral genetic medicine platform incorporates a novel DNA &hellip; Continue reading &quot;Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-22T11:49:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTM4NiM1MTY1OTM4IzIxOTY5Mjg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit\",\"datePublished\":\"2022-09-22T11:49:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\\\/\"},\"wordCount\":263,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1MTM4NiM1MTY1OTM4IzIxOTY5Mjg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\\\/\",\"name\":\"Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1MTM4NiM1MTY1OTM4IzIxOTY5Mjg=\",\"datePublished\":\"2022-09-22T11:49:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1MTM4NiM1MTY1OTM4IzIxOTY5Mjg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1MTM4NiM1MTY1OTM4IzIxOTY5Mjg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/","og_locale":"en_US","og_type":"article","og_title":"Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) &#8212; Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that the company will participate in a fireside chat at the 2022 Jefferies Cell &amp; Genetic Medicine Summit on Thursday, September 29th at 10:30 a.m. ET in New York. A live webcast of the presentation will be available on the investor section of the company\u2019s website at investors.generationbio.com. A replay will be available there for 30 days following the event. About Generation Bio Generation Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company\u2019s non-viral genetic medicine platform incorporates a novel DNA &hellip; Continue reading \"Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-22T11:49:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTM4NiM1MTY1OTM4IzIxOTY5Mjg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit","datePublished":"2022-09-22T11:49:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/"},"wordCount":263,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTM4NiM1MTY1OTM4IzIxOTY5Mjg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/","name":"Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTM4NiM1MTY1OTM4IzIxOTY5Mjg=","datePublished":"2022-09-22T11:49:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTM4NiM1MTY1OTM4IzIxOTY5Mjg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTM4NiM1MTY1OTM4IzIxOTY5Mjg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-2022-jefferies-cell-and-genetic-medicine-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/687934","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=687934"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/687934\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=687934"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=687934"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=687934"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}